Printer Friendly

NEORX DECLARES DIVIDEND

 NEORX DECLARES DIVIDEND
 SEATTLE, April 21 /PRNewswire/ -- NeoRx Corporation (NASDAQ: NERX)


today reported that its board of directors declared a cash dividend of $1.21875 per share on its preferred stock, Series 1, payable June 1, 1992, to holders of record at the close of business on May 21, 1992.
 NeoRx Corporation develops targeted biopharmaceutical products that detect and treat human illnesses with a primary focus on cancer. The company has three cancer therapy trials in progress, has filed for marketing approval with the FDA for two OncoTrac(R) cancer imaging products and has completed a phase III trial for a third. Targeted biopharmaceuticals to treat cancer, restenosis after angioplasty and autoimmune diseases are in pre-clinical testing.
 -0- 4/21/92
 /CONTACT: Robert M. Littauer, vice president, CFO and treasurer of NeoRx, 206-281-7001, ext. 519; or Anthony J. Russo or Susan A. Noonan of Noonan/Russo Communications, 212-979-9180, for NeoRx/
 (NERX) CO: NeoRx Corporation ST: Washington IN: MTC SU: DIV


GK-AH -- NY094 -- 0811 04/21/92 15:30 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 21, 1992
Words:169
Previous Article:JEFFERSON-PILOT SHAREHOLDER GROUP USES VIDEO TO FIGHT PROXY BATTLE
Next Article:RAIL UNIT LEADS CSX EARNINGS INCREASE


Related Articles
NEORX DECLARES DIVIDEND
NEORX DIVIDEND NOTICE
NEORX DIVIDEND NOTICE
NEORX CORPORATION DIVIDEND NOTICE
NEORX DIVIDEND NOTICE
NEORX DIVIDEND NOTICE
NEORX DIVIDEND NOTICE
NEORX DIVIDEND NOTICE
NeoRx Declares Dividend
NeoRx Declares Dividend

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters